Benchmark Downgrades Harvard Bioscience Inc. (HBIO) to Speculative Sell
Tweet Send to a Friend
Benchmark analyst Bruce Jackson downgraded Harvard Bioscience Inc. (NASDAQ: HBIO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
